Active	Status	Sponsor type	Region	Phase	Filter
17 Active 2 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Abercrombie, Melissa
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	Recruiting	N/A	450	US	COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device	Piomic Medical, NAMSA	Diabetic Foot Ulcer	06/27	06/27
Achong, Angel
CHANGE AFIB, NCT05130268: Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation	Completed	4	339	US	Dronedarone, Multaq	American Heart Association, Duke Clinical Research Institute, Sanofi	Atrial Fibrillation	01/24	06/24
NCT05805046: Study of Avelle™ Negative Pressure Wound Therapy (NPWT) System	Withdrawn	N/A	59	US	Negative Pressure Wound Therapy System, Avelle™ Negative Pressure Wound Therapy System	ConvaTec Inc.	Surgical Wound, Recent, Surgical Wound Leak, Dehiscence Wound, Trauma-related Wound	10/23	10/23
NCT05590715: International Multicentric Observational Study to Characterize Subpopulations of Patients with Autism Spectrum Disorder	Recruiting	N/A	1500	Europe, US, RoW		Stalicla SA	Autism Spectrum Disorder	12/25	12/25
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	Recruiting	N/A	450	US	COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device	Piomic Medical, NAMSA	Diabetic Foot Ulcer	06/27	06/27
Garcia, Mari
NCT05543707: PBI-0451 (Pomotrelvir) Phase 2 Study in Nonhospitalized Symptomatic Adults With COVID-19	Terminated	2	242	US	PBI-0451 (Pomotrelvir), Active, Placebo	Pardes Biosciences, Inc.	COVID-19	01/23	04/23
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	Recruiting	N/A	450	US	COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device	Piomic Medical, NAMSA	Diabetic Foot Ulcer	06/27	06/27
Ruiz, Heliodoro
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	Recruiting	N/A	450	US	COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device	Piomic Medical, NAMSA	Diabetic Foot Ulcer	06/27	06/27
Hernandez, Margarita
NCT06737042: Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants	Not yet recruiting	2	285	US	GZR18, Tirzepatide	Gan and Lee Pharmaceuticals, USA	Obesity and Overweight	02/26	06/26
NCT06681428: Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers	Recruiting	N/A	240	US	Allograft	Tides Medical, Professional Education and Research Institute	Diabetic Foot Ulcer (DFU), Chronic Foot Ulcers	11/26	11/26
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	Recruiting	N/A	450	US	COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device	Piomic Medical, NAMSA	Diabetic Foot Ulcer	06/27	06/27
Roukis, Thomas
Mavericks, NCT05758545: Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers	Recruiting	N/A	450	US	COMS One device, Concurrent Optical and Magnetic Stimulation, Sham device	Piomic Medical, NAMSA	Diabetic Foot Ulcer	06/27	06/27